What is CRISPR Therapeutics's change in AR?

CRISPR Therapeutics (CRSP) reported change in AR of -$0 in Q1 2026.

How has CRISPR Therapeutics's change in AR changed year-over-year?

CRISPR Therapeutics's change in AR increased by 100.0% year-over-year, from -$25M to -$0.

What is the long-term trend for CRISPR Therapeutics's change in AR?

Over 2 years (2021 to 2023), CRISPR Therapeutics's change in AR has grown at a 3424.5% compound annual growth rate (CAGR), from $161K to $200M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

CRISPR Therapeutics CRSP Change in AR

Change in AR at other companies

CG OncologyCGON

$587K—

Arrowhead ResearchARWR

$212.05M+8,382%

BridgeBio PharmaBBIO

$65.78M-40.5%

Krystal Biotech, Inc.KRYS

-$58K+96.1%

RevvityRVTY

-$61.55M-239%

Regeneron PharmaceuticalsREGN

-$1.2M+99.8%

Other financials

Income statement

See full

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

See full

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Total assets$2.7B+25.8%

Cash flow

See full

Operating cash flow-$108.9M-102%

CapEx$504.0K+145%

Free cash flow-$109.4M-102%

Valuation

See full

Market cap$5.33B+56.4%

Enterprise value$5.69B+69.8%

P/S1,298.3×+1,208×

Profitability

See full

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

See full

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Reported directly by CRISPR Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CRISPR Therapeutics's change in AR?: CRISPR Therapeutics (CRSP) reported change in AR of -$0 in Q1 2026.
How has CRISPR Therapeutics's change in AR changed year-over-year?: CRISPR Therapeutics's change in AR increased by 100.0% year-over-year, from -$25M to -$0.
What is the long-term trend for CRISPR Therapeutics's change in AR?: Over 2 years (2021 to 2023), CRISPR Therapeutics's change in AR has grown at a 3424.5% compound annual growth rate (CAGR), from $161K to $200M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.